Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Chin Med J (Engl) ; 134(20): 2430-2437, 2021 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-34669636

RESUMEN

BACKGROUND: Circulating tumor DNA (ctDNA) is a promising biomarker for non-invasive epidermal growth factor receptor mutations (EGFRm) detection in lung cancer patients, but existing methods have limitations in sensitivity and availability. In this study, we used the ΔCt value (mutant cycle threshold [Ct] value-internal control Ct value) generated during the polymerase chain reaction (PCR) assay to convert super-amplification-refractory mutation system (superARMS) from a qualitative method to a semi-quantitative method named reformed-superARMS (R-superARMS), and evaluated its performance in detecting EGFRm in plasma ctDNA in patients with advanced lung adenocarcinoma. METHODS: A total of 41 pairs of tissues and plasma samples were obtained from lung adenocarcinoma patients who had known EGFRm in tumor tissue and were previously untreated. EGFRm in ctDNA was identified by using superARMS. Through making use of ΔCt value generated during the detection process of superARMS, we indirectly transform this qualitative detection method into a semi-quantitative PCR detection method, named R-superARMS. Both qualitative and quantitative analyses of the data were performed. Kaplan-Meier analysis was performed to estimate the progression-free survival (PFS) and overall survival (OS). Fisher exact test was used for categorical variables. RESULTS: The concordance rate of EGFRm in tumor tissues and matched plasma samples was 68.3% (28/41). At baseline, EGFRm-positive patients were divided into two groups according to the cut-off ΔCt value of EGFRm set at 8.11. A significant difference in the median OS (mOS) between the two groups was observed (EGFRm ΔCt ≤8.11 vs. >8.11: not reached vs. 11.0 months; log-rank P = 0.024). Patients were divided into mutation clearance (MC) group and mutation incomplete clearance (MIC) group according to whether the ΔCt value of EGFRm test turned negative after 1 month of treatment. We found that there was also a significant difference in mOS (not reached vs. 10.4 months; log-rank P = 0.021) between MC group and MIC group. Although there was no significant difference in PFS between the two groups, the two curves were separated and the PFS of MC group tended to be higher than the MIC group (not reached vs. 27.5 months; log-rank P = 0.088). Furthermore, EGFRm-positive patients were divided into two groups according to the cut-off of the changes in ΔCt value of EGFRm after 1 month of treatment, which was set at 4.89. A significant difference in the mOS between the two groups was observed (change value of ΔCt >4.89 vs. ≤4.89: not reached vs. 11.0 months; log-rank P = 0.014). CONCLUSIONS: Detecting EGFRm in ctDNA using R-superARMS can identify patients who are more likely sensitive to targeted therapy, reflect the molecular load of patients, and predict the therapeutic efficacy and clinical outcomes of patients.


Asunto(s)
Adenocarcinoma del Pulmón , ADN Tumoral Circulante , Neoplasias Pulmonares , Adenocarcinoma del Pulmón/genética , ADN Tumoral Circulante/genética , Receptores ErbB/genética , Humanos , Neoplasias Pulmonares/genética , Mutación/genética , Inhibidores de Proteínas Quinasas
2.
Materials (Basel) ; 9(3)2016 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-28773302

RESUMEN

Damage to carbon nanotubes (CNTs) during the fabrication process of CNT reinforced composites has great influence on their mechanical properties. In this study, the 2014 Al with powder sizes of 20, 9 and 5 µm was selected to study the effect of initial particle size on the damage to carbon nanotubes (CNTs) during ball milling. The result shows that for CNTs in the ball milled CNT/Al (with powder size of 20 and 9 µm) mixtures, the intensity ratio of the D band and the G band (ID/IG) first increased and then reached a plateau, mainly because most of the CNTs are embedded, to a certain extent, in the aluminum powder after milling, which could protect the CNTs from damage during further milling. While for CNTs in the ball milled CNT/Al (with powder size of 5 µm) mixture, the ID/IG ratio continues to climb from 1.31 to 2.33 with time, indicating continuous damage to the CNTs occurs during the milling. Differential scanning calorimetry (DSC) analysis demonstrates that the chemical instability increased with an increase in the damage level of CNTs, resulting in the formation of aluminum carbide (Al4C3) at a lower temperature before the melting of aluminum, which is detrimental to their mechanical properties.

3.
Virology ; 397(2): 270-6, 2010 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-19962172

RESUMEN

MDV-GX0101 is a field strain of Marek's disease virus with a naturally occurring insertion of the reticuloendotheliosis virus (REV) LTR fragment. In order to study the biological properties of REV-LTR insertion in the MDV genome, we constructed a full-length infectious BAC clone of MDV-GX0101 strain and deleted the LTR sequences by BAC mutagenesis. The pathogenic properties of the LTR-deleted virus were evaluated in infected SPF birds. The study demonstrated that the LTR-deleted virus had a stronger inhibitory effect on the growth rates of the infected birds and induced stronger immunosuppressive effects. Surprisingly, however, the ability for horizontal transmission of the LTR-deleted virus appeared to be significantly weaker than its parental LTR-intact virus. Even though the precise molecular mechanisms are still not clear, the results of our studies demonstrate that the retention of the REV-LTR in the MDV genome decreases its pathogenic effects but increases its potential for horizontal transmission.


Asunto(s)
Mardivirus/genética , Mardivirus/patogenicidad , Enfermedad de Marek/patología , Mutagénesis Insercional , Recombinación Genética , Virus de la Reticuloendoteliosis/genética , Secuencias Repetidas Terminales/genética , Animales , Aves/virología , ADN Viral/química , ADN Viral/genética , Terapia de Inmunosupresión , Enfermedad de Marek/inmunología , Enfermedad de Marek/transmisión , Enfermedad de Marek/virología , Datos de Secuencia Molecular , Análisis de Secuencia de ADN , Eliminación de Secuencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...